Published in Clinical Oncology Week, June 14th, 2004
"Proteomics has become an important part in the leading research area and been widely used in the disease-associated study," scientists writing in the journal Science in China report.
"In hepatic research field, proteomics could be applied in study of hepatic diseases including liver cancer, cirrhosis, and hepatotoxicities, etc.," wrote W. Sun and colleagues, Beijing Institute of Radiation Medicine.
The researchers concluded: "Significant proteins could be identified as biomarkers, drug targets...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Clinical Oncology Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.